Prohibits the sale of kratom to individuals under the age of twenty-one; prohibits the sale or dissemination of information recorded during transaction scans; imposes a civil penalty of not more than five hundred dollars for the sale or provision of kratom to any person under the age of twenty-one; repeals certain provisions relating thereto; repeals certain provisions requiring a study on kratom; relates to the effectiveness of a chapter of the laws of 2025 relating to prohibiting the sale of kratom to persons under the age of 21.
Impact
The proposed legislation represents a modification of existing health laws concerning the sale of kratom and aims to enhance public health protection by preventing minors from accessing substances that could affect their health. By clearly defining the responsibilities of kratom sellers and establishing penalties for non-compliance, the bill seeks to mitigate potential risks associated with kratom use among younger populations. The bill also repeals previous provisions that required studies on the effects of kratom, suggesting a shift in legislative focus towards immediate regulatory measures instead of ongoing research.
Summary
Bill A09472 proposes to prohibit the sale of kratom to individuals under the age of twenty-one. This legislation aims to regulate the distribution of kratom, a substance derived from the Mitragyna speciosa tree, which has been subject to scrutiny regarding its safety and effects. The bill specifies that it will impose civil penalties for violations, setting a maximum fine of five hundred dollars for the sale or provision of kratom to underage individuals. Furthermore, it mandates that sellers post conspicuous signs indicating the prohibition of selling kratom to minors in various retail formats, including physical locations and online platforms.
Contention
Discussions around A09472 may involve differing opinions about the regulation of kratom. Proponents of the bill argue that stricter regulations are necessary to protect youth from possible health risks associated with kratom, which has been linked to adverse effects in some users. However, critics may raise concerns about limiting access to a product that is legal for adults, questioning the necessity of such regulations and their potential impact on consumers and businesses. Some may argue for the need for further study on kratom instead of immediate restrictions, reflecting the ongoing debate about the balance between public health and personal freedom in the sale of herbal substances.
Same As
Prohibits the sale of kratom to individuals under the age of twenty-one; prohibits the sale or dissemination of information recorded during transaction scans; imposes a civil penalty of not more than five hundred dollars for the sale or provision of kratom to any person under the age of twenty-one; repeals certain provisions relating thereto; repeals certain provisions requiring a study on kratom; relates to the effectiveness of a chapter of the laws of 2025 relating to prohibiting the sale of kratom to persons under the age of 21.
Prohibits the sale of kratom to individuals under the age of twenty-one; prohibits the sale or dissemination of information recorded during transaction scans; imposes a civil penalty of not more than five hundred dollars for the sale or provision of kratom to any person under the age of twenty-one; repeals certain provisions relating thereto; repeals certain provisions requiring a study on kratom; relates to the effectiveness of a chapter of the laws of 2025 relating to prohibiting the sale of kratom to persons under the age of 21.
Prohibits the sale of kratom to individuals under the age of twenty-one; imposes a civil penalty of not more than five hundred dollars for the sale or provision of kratom to any person under the age of twenty-one.
Prohibits the sale of kratom to individuals under the age of twenty-one; imposes a civil penalty of not more than five hundred dollars for the sale or provision of kratom to any person under the age of twenty-one.
Enacts the "synthetic kratom kills act" to prohibit harmful synthetic and adulterated kratom products; provides that no person, manufacturer, retailer, or other entity shall manufacture, distribute, sell, or offer for sale: synthesized kratom material; any adulterated kratom product; a kratom product that is combustible or intended to be used for vaporization, aerosolization, or injection; a kratom product that is incorporated into, or marketed or labeled as, a conventional food or beverage product; a kratom product that contains flavoring agents or additives specifically designed or marketed to appeal to individuals under twenty-one years of age; a kratom product not contained in child-resistant packaging; a kratom product that mimics a candy product or is manufactured, packaged, or advertised in a way that can be reasonably considered to appeal to individuals under twenty-one years of age; any kratom product to an individual under twenty-one years of age; and any kratom product in which the concentration of 7-hydroxymitragynine exceeds two percent of the concentration of total alkaloids; requires testing and clear labeling.
Prohibiting the preparation, manufacture, sale or distribution of unsafe kratom products and the sale or distribution of kratom products to individuals younger than 21 years of age; providing for duties of Department of Health; and imposing penalties.